Tag: exclusive license

June 5, 2018

Verastem Oncology and Yakult Sign Exclusive Licensing Agreement

Verastem Oncology is set to receive an upfront payment of US$10 million–and may be eligible to receive up to $90...
May 10, 2018

Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan

Aquinox Pharmaceuticals (NASDAQ:AQXP) a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood...
May 10, 2018

Parana Copper Corp Provides an Update on Redfund Capital Corp Projects

Parana Copper Corporation (CSE:COPR) (OTC:PNNRF) (Frankfurt:O3X4) (the “Company”) introduces CBD ZONE LLC (“CBD”) and their beverage dosing technology as the...
May 9, 2018

INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East

INSYS Therapeutics (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that...
May 7, 2018

HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

HTG Molecular Diagnostics (NASDAQ:HTGM) a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A., a provider of...
May 2, 2018

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
April 26, 2018

INDIVA Granted Exclusive Rights to DeepCell™ Industries’ Products in Canada

INDIVA Limited (TSXV:NDVA) (the "Company" or "INDIVA") is pleased to announce an exclusive license agreement with, and a USD $1.5...